Centenarians Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 06-01-2025
- Paid Up Capital ₹ 0.14 M
as on 06-01-2025
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 06-01-2025
About Centenarians Life Sciences
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.14 M.
The company currently has active open charges totaling ₹5.00 Cr.
Rakesh Somani, Parth Amin, and Darshit Patel serve as directors at the Company.
- CIN/LLPIN
U24299GJ2021PTC124384
- Company No.
124384
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Centenarians Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Somani  | Director | 29-Jul-2021 | Current |
| Parth Amin | Director | 26-Jul-2021 | Current |
| Darshit Patel | Director | 26-Jul-2021 | Current |
Financial Performance of Centenarians Life Sciences.
Centenarians Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Centenarians Life Sciences?
Unlock access to Centenarians Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cyber Cloud Shield Broadband Services Private LimitedActive 10 years 1 monthParth Amin is a mutual person
Charges (Loans)
₹50.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2023 | Axis Bank Limited | ₹5.00 Cr | Open |
How Many Employees Work at Centenarians Life Sciences?
Centenarians Life Sciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centenarians Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centenarians Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.